Data from a Phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer.
A data frame with 41 observations on the following 4 variables.
a factor with levels
LA (locally advanced) or
date of enrollment into the clinical trial, in month/day/year format
date of progression, in month/day/year format
date of death, in month/day/year format
Since all patients in this study have known death dates, there is no censoring.
Moss RA, Moore D, Mulcahy MF, Nahum K, Saraiya B, Eddy S, Kleber M, and Poplin EA (2012) A multi-institutional phase 2 study of imatinib mesylate and gemcitabine for first-line treatment of advanced pancreatic cancer. Gastrointestinal Cancer Research 5, 77 - 83.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.